Evaluation of Specialty Pharmacy in an Integrated Health-System

Size: px
Start display at page:

Download "Evaluation of Specialty Pharmacy in an Integrated Health-System"

Transcription

1 Evaluation of Specialty Pharmacy in an Integrated Health-System Emma Chermely, PharmD, BCACP Alyssa McCann, PharmD, BCACP *The presenters have no conflicts of interest to disclose.

2 Objectives Introduce the background of specialty pharmacy Evaluate UC Health s Specialty Pharmacy patient population and services Describe the impact a specialty pharmacy can have within a health-system Describe the various role for pharmacy technicians within a specialty pharmacy*. * Technician Learning objective

3 What is a specialty pharmacy? State-licensed pharmacies that solely or largely provide only medications for serious complex health conditions Connect severely ill patients with disease specific high cost, high touch medications Provide patient care services Support patients through reimbursement challenges Excellent services drive adherence and ensure appropriate medication use The National Association of Specialty Pharmacy. NASP Definitions of Specialty Pharmacy and Specialty Medications (Feb 2016). (accessed 25 Mar 2018). M Goldenhorn, R Smith, PT Rocafort. Understanding the high-touch model. Getting acquainted with specialty pharmacy (Mar 2014). ACPE CE. (accessed 25 Mar 2018).

4 What are specialty medications? Medications that require intensive patient management May require special handling, storage and/or administration May be administered orally, subcutaneously, or intravenously May cost up to $750,000 per year Require comprehensive patient care, clinical management, and product support services The National Association of Specialty Pharmacy. NASP Definitions of Specialty Pharmacy and Specialty Medications (Feb 2016). (accessed 25 Mar 2018). M Goldenhorn, R Smith, PT Rocafort. Understanding the high-touch model. Getting acquainted with specialty pharmacy (Mar 2014). ACPE CE. (accessed 25 Mar 2018).

5 Impact of Specialty Medications AJPB Top 5 Medications Humira Harvoni Enbrel Rituxan Remicade AJHP Top 5 Medications Humira Lantus Harvoni Enbrel Remicade Spending on specialty medications doubled from 2010 to 2015 Specialty medications contributed 70% to overall growth of drug expenditures Toich L. Top 5 highest-selling drugs of AJPB (Aug 2017) (accessed 25 Mar 2018) Shumock et al. National trends in prescription drug expenditures and projections for AJHP (May 2017). (accessed 2018 Mar 25) IMS Institute for Healthcare Informatics. Medicines use and spending in the U.S. A review of 2015 and outlook to 2020 (April 2016). www. imshealth.com/en/thoughtleadership/quintilesims-institute/reports/ medicines-use-and-spending-in-the-us-a-review-of-2015-and-outlook-to-2020 (accessed 2018 Mar 25).

6 Growth of Specialty Pharmacies Figure 1. Pharmacy Locations with Specialty Pharmacy Accreditation by Corporate Ownership 2015 vs 2016 CAGR: compound annual growth rate Figure 2. Pharmacy Industry Prescription Revenue ($ Billions) Steiber, Dan. Proving value in specialty pharmacy practice: a new yardstick. AJPB (Nov/Dec 2017). (accessed 25 Mar 2018).

7 Health-System Specialty Models University of Utah Health Care Implemented in 2014 Added 8 technician FTE and 1 pharmacist FTE Goals: 1. Develop centralized prior authorization (PA) process 2. Develop a call center to provide specialty pharmacy services 3. Utilize Electronic Medical Record (EMR) documentation Program Results 137% increase in specialty pharmacy revenue in fiscal year 2015 Average PA approval time of 3 business days Excluded cases involving denials or appeals Rim M. Am J Health Syst Pharm Jun 1; 73(11):831-8.

8 Health-System Specialty Models Vanderbilt Specialty Pharmacy 20 specialty clinics 24 clinical pharmacists and 20 technicians Specialty pharmacists and technicians work from clinic Services are tailored to individual clinic Basic Services Patient counseling Benefits Investigating/Prior Authorization Financial counseling Refill reminder calls 24-hour on-call pharmacist Free shipping Customizable Services Assist in medication selection Lab monitoring Collaborative Practice Agreement Adherence monitoring REMS program management Independent pharmacist clinic visits Bagwell A. J Manag Care Spec Pharm, 2017 Aug; 23(8):

9 UC Health Specialty Pharmacy Opened in October 2016 Obtained URAC Accreditation in July 2017 Staffing: 4.5 pharmacists and 2 technicians Service lines covered Solid Organ Transplant Oncology/Hematology Infectious Diseases Gastroenterology Neurology (Multiple Sclerosis) Cardiology

10 UC Health Specialty Pharmacy Workflow Technician Technician xx Benefits Investigation xx Initiate Prior Authorization xx Approved Document Document Document Uninsured xxmedication Access Referral Z Insured xx Denied High Copay Z Dispense or Transfer Technician Technician Document

11 UC Health Specialty Pharmacy Workflow Initial Assessment Refill Call Routine Assessment

12 UC Health Specialty Pharmacy TherigySTM utilized as patient management system Not integrated with Epic Cloud-based product that contains: Patient demographics Therapeutic category Medication Prior authorization information Various activities Medication refills, clinical assessments, clinical interventions

13 Patients UC Health Specialty Pharmacy Patients HCV HIV Hem/Onc Transplant Other Disease State Total 1,189 Patients

14 Transplant Type Patients by Transplant Type Transplant Service started in October pharmacist Coordinate, fill, and ship all medications for patient Initial and quarterly assessment If > 3 years from transplant, annual assessments Recent study showed improved Proportion of Days Covered (PDC) with specialty pharmacy 88% to 97% (p<0.001) Pancreas Kidney/Pancreas Kidney/Liver Liver Kidney Heart/Kidney Heart Patients

15 Human Immunodeficiency Virus (HIV) Service rapidly expanded in January Active Patients 1.5 Clinical Pharmacists 1 Technician

16 Hepatitis C (HCV) 143 Active Patients 1 Clinical Pharmacist Prior Authorization (PA) turnaround time of 4 business days Month Total Prior Authorizations Prescriptions filled at Specialty January February 32 14

17 Hematology/Oncology 134 Active Patients 16 Hematology 118 Oncology 1 Clinical Pharmacist PA turnaround time of 2 business days Month Total Prior Authorizations Prescriptions filled at Specialty January February 27 14

18 Additional Benefits of an Integrated Specialty Pharmacy Decreased fragmentation Coordinated care within one health-system Utilization of patient s medical record for communication Improved access to medication for patients Increased patient and provider satisfaction

19 UC Health Medication Access Services Operate with 1 Coordinator and 6 Advocates Highly integrated within UC Health Assist patients and providers with Review and Verification of Insurance Coverage Insurance Benefit Selection Medicare Part D and Medicare Extra Help Diagnosis-specific Foundation Assistance Pharmaceutical-specific Co-pay Assistance Pharmaceutical-specific Patient Assistance Programs 30% of specialty patients utilize these services

20 Revenue Number of Patients $180, $160, $140, $120, $100, $80, $60, $40, $20, $- Specialty Pharmacy Revenue from Medication Access Services January February March April May June July August September October November December January Month Number of Patients Revenue

21 Cost Avoidance Number of Patients $250, $200, Specialty Pharmacy Cost Avoidance from Medication Access Services $150, $100, $50, $- January February March April May June July August September October November December January Month 0 Cost Avoidance Number of Patients

22 UC Health Specialty Pharmacy Quality Management Satisfaction surveys conducted quarterly Utilizes a 5 point Likert scale Overall satisfaction of 4.87 and 4.91 for providers and patients Majority of patients received medications via mail Lowest score was affordability of medications 97.3% of patients would recommend UC Health Specialty Pharmacy 91.3% of providers would strongly recommend UC Health Specialty Pharmacy to colleagues

23 UC Health Specialty Pharmacy Growth *Includes data through 1/31/18

24 UC Health Specialty Pharmacy Growth *Includes data through 1/31/18

25 UC Health Specialty Pharmacy Barriers to Care Patient population Limited access to medications Medication cost Pharmacy Benefit Manager (PBM) restrictions Ohio is not an any willing provider state

26 UC Health Specialty Pharmacy Future Directions Increase staffing Individualized roles for pharmacy technicians Expansion to more specialty clinics Increase access to medications Incorporation of the 4 P s Patient Providers Pharma Payers

27 Active Learning #1 According to AJPB and AJHP, what was the top selling specialty medication in 2016? A. Imbruvica B. Harvoni C. Prograf D. Humira

28 Active Learning #2 What are the 4 P s of Specialty Pharmacy? A. Patient, Product, Providers, Pharmacy B. Patient, Product, Pharma, Payers C. Patient, Providers, Pharma, Payers D. Patient, Providers, Pharmacy, Payers

29 Evaluation of Specialty Pharmacy in an Integrated Health-System Emma Chermely, PharmD, BCACP Alyssa McCann, PharmD, BCACP *The presenters have no conflicts of interest to disclose.

Justifying New Oncology Pharmacist Positions

Justifying New Oncology Pharmacist Positions Faculty Disclosures Justifying New Oncology Pharmacist Positions I will not be discussing off-label uses of any medications I am on the speaker s bureau for Millenium Pharmaceuticals and am a paid consultant

More information

The Un-Special World of Specialty Medications

The Un-Special World of Specialty Medications The Un-Special World of Specialty Medications Manpreet Chahal, PharmD, PhD Oncology Pharmacist, Medical Oncology Associates, Spokane WA Adjunct Clinical Instructor, WSU College of Pharmacy mschahal@wsu.edu

More information

Walgreens Enterprise Specialty Pharmacy

Walgreens Enterprise Specialty Pharmacy Walgreens Enterprise Specialty Pharmacy Chris Creamer Senior Director, Specialty Operations August 17, 2017 Member of Walgreens Boots Alliance Core objectives for today at a glance Discuss the Key Market

More information

Panel Discussion: Orals Adherence & Challenges Friday, April 28 th, 2017

Panel Discussion: Orals Adherence & Challenges Friday, April 28 th, 2017 Panel Discussion: Orals Adherence & Challenges Friday, April 28 th, 2017 1 2017 Community Oncology Alliance Panel Discussion: Orals Adherence & Challenges Ray Bailey, RPh, Director of Pharmacy Florida

More information

Community-Based Point-of-Care Testing: From Innovative Care Model to Common Practice

Community-Based Point-of-Care Testing: From Innovative Care Model to Common Practice Community-Based Point-of-Care Testing: From Innovative Care Model to Common Practice Donald G. Klepser, PhD, MBA Associate Professor University of Nebraska Medical Center Brian Bobby Rite Aid Vice President,

More information

Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star

Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star HEALTH ALLIANCE PLAN Presented by Vanita K. Pindolia, Pharm.D. VP, Ambulatory Clinical Pharmacy Programs_PCM Medicare 5-Star Rating

More information

9/25/15. Pharmacy Quality Measures: Financial Support. Learning Objectives. Speaker Disclosure. Access to Preferred Networks and Clinical Performance

9/25/15. Pharmacy Quality Measures: Financial Support. Learning Objectives. Speaker Disclosure. Access to Preferred Networks and Clinical Performance Pharmacy Quality Measures: Action Steps for Improvement Financial Support Financial support was provided for this activity through an unrestricted grant from Health Mart Systems, Inc. Christine Jacobson

More information

Role of the Clinical Pharmacist in Primary Care

Role of the Clinical Pharmacist in Primary Care Role of the Clinical Pharmacist in Primary Care Amy Kramer, Pharm.D., Manager Clinical Pharmacy Services Kaiser Permanente Holly Miller, Pharm.D., BCACP, Primary Care Clinical Pharmacist Kaiser Permanente

More information

Navigating The Prior Authorization Approval Process. Kristin Webb, RPCA University at Buffalo

Navigating The Prior Authorization Approval Process. Kristin Webb, RPCA University at Buffalo Navigating The Prior Authorization Approval Process Kristin Webb, RPCA University at Buffalo Disclosures DISCLOSURES Commercial Entity Relevance Role K. Webb Abbvie Merck, AbbVie, Tobira, Gilead Honorarium

More information

Navigating The Prior Authorization Approval Process

Navigating The Prior Authorization Approval Process Navigating The Prior Authorization Approval Process Kristin Webb, RPCA University at Buffalo Disclosures DISCLOSURES Commercial Entity Relevance Role K. Webb Abbvie Merck, AbbVie, Tobira, Gilead Honorarium

More information

How one pharmacy is bringing specialty drugs to an independent community pharmacy setting

How one pharmacy is bringing specialty drugs to an independent community pharmacy setting , S E Y t a h t it s How one pharmacy is bringing specialty drugs to an independent community pharmacy setting by LeAnn W. O Neill, PharmD; Vanessa K. Hoffman, PharmD, CGP; Barry S. Bryant, RPh; and John

More information

Population Health Management Design: Optimizing the Outcomes for Special Populations 21th Annual ASHP Conference for Pharmacy Leaders

Population Health Management Design: Optimizing the Outcomes for Special Populations 21th Annual ASHP Conference for Pharmacy Leaders Learning objectives Define population health and its impact on pharmacy leaders. Population Health Management Design: Optimizing the Outcomes for Special Populations Meghan D. Swarthout, PharmD, MBA, BCPS

More information

Pre-exposure Prophylaxis for HIV Prevention

Pre-exposure Prophylaxis for HIV Prevention Mountain West AIDS Education and Training Center Pre-exposure Prophylaxis for HIV Prevention Cost and Access: Tips from the Field Joanne Stekler, MD MPH October 12, 2017 This presentation is intended for

More information

Comprehensive support for your patients on MYALEPT

Comprehensive support for your patients on MYALEPT Comprehensive support for your patients on MYALEPT Insurance and financial assistance options (see page 3) Fulfillment support (see page 6) Co-pay assistance a,b (see page 4) Your patient Injection training

More information

Tips for Evolving Medicaid Pharmacy Benefits Management (PBM) Programs. June 5, 2015

Tips for Evolving Medicaid Pharmacy Benefits Management (PBM) Programs. June 5, 2015 Tips for Evolving Medicaid Pharmacy Benefits Management (PBM) Programs 1 June 5, 2015 Introductions Mark Steck Pharm.D Independent Consultant, MAXIMUS John J.P. Crouse Vice President, MAXIMUS Market Lead

More information

Pharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica

Pharmacy Trends and Management Opportunities. Kerry Bendel, R.Ph. Director of Pharmacy Medica Pharmacy Trends and Management Opportunities Kerry Bendel, R.Ph. Director of Pharmacy Medica September 14, 20 1 Agenda Pharmacy Trend Experience Trend Drivers and Management Opportunities Call to Action

More information

THE GROWTH OF SPECIALTY PHARMACY

THE GROWTH OF SPECIALTY PHARMACY UnitedHealth Center for Health Reform & Modernization THE GROWTH OF SPECIALTY PHARMACY Current trends and future opportunities Issue Brief April 2014 Summary Innovative specialty drugs are providing important

More information

2015 Annual Convention

2015 Annual Convention 2015 Annual Convention Date: Tuesday, October 13, 2015 Time: 8:00 am 9:30 am Location: Gaylord National Harbor Resort and Convention Center, National Harbor 2 Title: Activity Type: Speaker: Benefit from

More information

Magellan Rx. A smarter approach to pharmacy benefits management

Magellan Rx. A smarter approach to pharmacy benefits management Magellan Rx A smarter approach to pharmacy benefits management Presented by: Cheri Caruso, VP of Sales, Magellan Rx Management Bryce Canfield, VP, Client Development, GoodRx A unique vision of care We

More information

Specialty Drugs in Workers Compensation

Specialty Drugs in Workers Compensation Specialty Drugs in Workers Compensation A GUIDE FOR CLAIMS HANDLERS Specialty Drugs Specialty drugs have been developed in response to demand for specialized medications for complex medical conditions.

More information

PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS

PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS PHARMACY BENEFITS MANAGER SELECTION FAQ FOR PRODUCERS For Producer Audience Only - Please Do Not Distribute Regence has selected Prime Therapeutics as the Pharmacy benefits manager for its health plans.

More information

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA 50315 (515) 974-3131 Fax 1-866-626-0216 Brett Faine, Pharm.D. Larry Ambroson, R.Ph. Casey Clor, M.D. Mark Graber, M.D.,

More information

Digital Technologies: The Solutions to Poor Medication Adherence?

Digital Technologies: The Solutions to Poor Medication Adherence? Digital Technologies: The Solutions to Poor Medication Adherence? Jeffrey Mesaros, PharmD Annual Meeting & Exposition Seattle, Washington March 22-25 1 Disclosures The views and opinions expressed in the

More information

MArch The 2014 Drug Trend Report Highlights

MArch The 2014 Drug Trend Report Highlights MArch 2015 The 2014 Drug Report Highlights Highest Increase in U.S. Drug Spend Over Past Decade In 2014, the pharmacy landscape underwent a seismic change, and the budgetary impact to healthcare payers

More information

Prescription Benefit Management. Eric Cannon, PharmD, FAMCP

Prescription Benefit Management. Eric Cannon, PharmD, FAMCP Prescription Benefit Management Eric Cannon, PharmD, FAMCP Agenda Drugs as a Share of Health Spending Top Drugs of 2016 Management Interventions and Strategies Specialty Pharmacy, Generics and Biologics

More information

Mary Ann Hodorowicz RDN, MBA, CDE, CEC (Certified

Mary Ann Hodorowicz RDN, MBA, CDE, CEC (Certified Mary Ann Hodorowicz RDN, MBA, CDE, CEC (Certified Endocrinology Coder) Mary Ann Hodorowicz, RDN, MBA, CDE, CEC, is a licensed registered dietitian and certified diabetes educator and earned her MBA with

More information

Utilization of Telemedicine to Treat Hepatitis C Virus Infection at a Medication Assisted Treatment Program

Utilization of Telemedicine to Treat Hepatitis C Virus Infection at a Medication Assisted Treatment Program Utilization of Telemedicine to Treat Hepatitis C Virus Infection at a Medication Assisted Treatment Program Collaborative Effort Between State University of New York - Buffalo Centers for Disease Control

More information

Oncology Pharmacy Navigator: A Novel Model for Medication Management

Oncology Pharmacy Navigator: A Novel Model for Medication Management Oncology Pharmacy Navigator: A Novel Model for Medication Management Kelly Rice, Pharm.D. Oncology Pharmacy Navigator Legacy Cancer Institute Portland, Oregon Objectives Understand the role of an oncology

More information

Positive Living Conference

Positive Living Conference Positive Living Conference Ft. Walton Beach, Thomas Liberti Chief, Bureau of HIV/AIDS Department of Health March 11, 2011 Tallahassee, 1 The Epidemic in, 2010 60% White Population: 18.8 million (4 th 16%

More information

16 th Annual IHA Stakeholders Meeting Session 2C

16 th Annual IHA Stakeholders Meeting Session 2C 16 th Annual IHA Stakeholders Meeting Session 2C September 19, 2017 Hilton Los Angeles Airport Thank you to our Content Partner: Medication Adherence AppleCare Pharmacy Programs Confidential and proprietary.

More information

Moving the Needle: How Are We Doing with Patient Adherence to Drug Therapy?

Moving the Needle: How Are We Doing with Patient Adherence to Drug Therapy? Moving the Needle: How Are We Doing with Patient Adherence to Drug Therapy? 2018 Patient Adherence Influence Report By Mike Occhipinti and Linda Morini 2018 Syneos Health. All rights reserved. MOVING THE

More information

Pharmacy Partnership to Improve Patient Outcomes

Pharmacy Partnership to Improve Patient Outcomes Pharmacy Partnership to Improve Patient Outcomes Minnesota Rural Health Conference Session 2B Ryan M. Harden, MD MS Kendra Metz, Pharm D Sarah Nelson, MD June 25, 2018 Involved Partners Involved Partners

More information

Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands

Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands Objectives Identify patient barriers to medication adherence. Describe the clinical and economic impact of

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Valcyte) Reference Number: ERX.NPA.33 Effective Date: 06.01.15 Last Review Date: 08.17 Line of Business: Commercial [Prescription Drug Plan] Revision Log See Important Reminder at the

More information

Helpful Resources for people with Diabetes

Helpful Resources for people with Diabetes Helpful Resources for people with Diabetes Help with Diabetes tablets and insulin The goal of the program is to help eligible uninsured and underinsured patients of all ages receive needed prescription

More information

AzPA Southwestern Clinical Seminar. JW Marriott Starr Pass Blvd., Tucson, AZ

AzPA Southwestern Clinical Seminar. JW Marriott Starr Pass Blvd., Tucson, AZ AzPA Southwestern Clinical Seminar JW Marriott 3800 Starr Pass Blvd., Tucson, AZ Time Program CE 8:00-9:30am Emerging Infectious Disease Outbreaks in Arizona, the U.S., and the World Lydia Plante, MSPH,

More information

Continuing Education. An integral member of the healthcare team Utilize creative technology Intentional in marketing

Continuing Education. An integral member of the healthcare team Utilize creative technology Intentional in marketing Upon successful completion of this article, the pharmacist (or pharmacy technician) should be able to: Describe the key points of the clinical community pharmacist Define the prevalence of the major chronic

More information

Market Distortions from the 340B Drug Pricing Program

Market Distortions from the 340B Drug Pricing Program Market Distortions from the 340B Drug Pricing Program Adam J. Fein, Ph.D. www.drugchannels.net @DrugChannels The opinions and views expressed in this presentation are those of the author and may not reflect

More information

ASCO s Quality Training Program

ASCO s Quality Training Program ASCO s Quality Training Program Project Title: Improving oral chemotherapy fulfillment processes and implementation of a pharmacistmanaged oral chemotherapy follow-up program Presenter s Name: Sonja Jacobsen,

More information

Are Specialty Pharmacy Drugs Worth the Cost? How Companies Can Make Them More Affordable.

Are Specialty Pharmacy Drugs Worth the Cost? How Companies Can Make Them More Affordable. Are Specialty Pharmacy Drugs Worth the Cost? How Companies Can Make Them More Affordable. BACKGROUND Your Host: Eric Bricker, MD Co-Founder & Chief Medical Officer - Compass Professional Health Services

More information

Vaccine Starter Kit Program FAQs

Vaccine Starter Kit Program FAQs Vaccine Starter Kit Program FAQs Program How does this program help Health Mart pharmacies provide vaccines for their customers? McKesson has designed a comprehensive program specifically for Health Mart

More information

Jefferies Healthcare Conference. June 2016

Jefferies Healthcare Conference. June 2016 Jefferies Healthcare Conference June 2016 Today s Speakers John Figueroa Chief Executive Officer Vic Breed Chief Financial Officer Joined Genoa in July 2014 Previously served the dual roles of CEO of Apria

More information

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE 37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE January 2019 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as

More information

Specialty pharmacy is one of the fastest growing areas of

Specialty pharmacy is one of the fastest growing areas of formulary Management Best Practices in Specialty Pharmacy Management Courtney J. Patterson, PharmD, BCOP ABSTRACT BACKGROUND: Specialty pharmacy is a growing area of research, utilization, and cost. Because

More information

Pharmacotherapy selection system supports shared clinician-patient decision-making in diabetes treatment

Pharmacotherapy selection system supports shared clinician-patient decision-making in diabetes treatment FOR IMMEDIATE RELEASE Pharmacotherapy selection system supports shared clinician-patient decision-making in diabetes treatment Electronic health record-based comparative display of pharmaceutical options

More information

SFDPH Responds to Hepatitis C: Strategic Directions for and Beyond

SFDPH Responds to Hepatitis C: Strategic Directions for and Beyond SFDPH Responds to Hepatitis C: Strategic Directions for 2015-2016 and Beyond Presented by: Kelly Eagen, MD Physician Specialist Tom Waddell Urban Health San Francisco Health Network Katie Burk, MPH Viral

More information

Specialty conditions overview

Specialty conditions overview Specialty conditions overview Prevalence and cost Click on the vials to learn more about these specialty conditions. 1. Approximate annual AWP cost per patient of top utilized drugs for UHC calendar year

More information

Adult Immunization Highlights from the 48th National Immunization Conference

Adult Immunization Highlights from the 48th National Immunization Conference Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Adult Immunization Highlights from the 48th National Immunization Conference Amy Parker Fiebelkorn,

More information

Colorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center

Colorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center Colorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center Kaela Momtselidze Health Systems Manager Primary Care Systems American Cancer Society Sheri Frank Director of Corporate

More information

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services: Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Addolorata

More information

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Assistant Clinical

More information

2016 Pharmacist Re-Licensure Survey Instrument

2016 Pharmacist Re-Licensure Survey Instrument 1. Sex a. Male b. Female 2016 Pharmacist Re-Licensure Survey Instrument 2. Ethnicity: Are you Hispanic or Latino? a. Yes b. No 3. Race (Check all that apply.) a. American Indian or Alaska Native b. Black

More information

These reports were prepared pursuant to directive contained in Section 10 of Senate File 2425 which is listed below:

These reports were prepared pursuant to directive contained in Section 10 of Senate File 2425 which is listed below: CHESTER J. CULVER, GOVERNOR PATTY JUDGE, LT. GOVERNOR DEPARTMENT OF HUMAN SERVICES EUGENE I. GESSOW, DIRECTOR January 15, 2009 Michael Marshall Secretary of Senate State Capitol LOCAL Mark Brandsgard Chief

More information

Getting started with Prime

Getting started with Prime Getting started with Prime How does a pharmacy plan work? When you visit your doctor, he or she may prescribe medicine for you. Here's how the plan works: Take your prescription and member ID card to the

More information

IMPACT OF DRUG REBATES ON YOUR PARTICIPANTS AND YOUR PLAN RISK PROFILE Indiana Health and Wellness Summit

IMPACT OF DRUG REBATES ON YOUR PARTICIPANTS AND YOUR PLAN RISK PROFILE Indiana Health and Wellness Summit IMPACT OF DRUG REBATES ON YOUR PARTICIPANTS AND YOUR PLAN RISK PROFILE 2018 Indiana Health and Wellness Summit National Diabetes Volunteer Leadership Council Who We Are Patient advocacy organization committed

More information

Using Decision Support to Promote Value Based Prescribing

Using Decision Support to Promote Value Based Prescribing Using Decision Support to Promote Value Based Prescribing Session 218, February 14, 2019 Adam Szerencsy, DO Medical Director, Ambulatory Informatics NYU Langone Health 1 Conflict of Interest Adam Szerencsy,

More information

Walgreens (WAG) Analyst: Juan Fabres Fall 2014

Walgreens (WAG) Analyst: Juan Fabres Fall 2014 Recommendation: Buy Target Price August 31, 2016: $77.57 1. Reasons for the Recommendation With the acquisition of Alliance Boots in Europe, Walgreens will be the first US pharmacy to operate retail stores

More information

Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data).

Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data). HIV Background, new developments, key strategies Drug Class Insight INTRODUCTION Human Immunodeficiency Virus (HIV) is the virus that can lead to Acquired Immunodeficiency Syndrome, or AIDS. No safe and

More information

Telemedicine: Connecting Behavioral Health and Medical Care

Telemedicine: Connecting Behavioral Health and Medical Care Telemedicine: Connecting Behavioral Health and Medical Care Lawrence S. Brown, Jr., MD, MPH, FASAM CEO, START Treatment & Recovery Centers Clinical Associate Professor of Medicine and Health Care and Policy

More information

How Mail-Servi. Prepared for

How Mail-Servi. Prepared for How Mail-Servi ice Pharmacies Will Save $46.6 Billion Over the Next Decade and the Cost of Proposed Restrictions Prepared for February 2012 Table of Contents I. Executive Summary... 3 Major Findings on

More information

ACIP Recommendations for Adult Pneumococcal Immunization: Helping Pharmacists Assess, Recommend, Administer or Refer. Interim Outcomes Report

ACIP Recommendations for Adult Pneumococcal Immunization: Helping Pharmacists Assess, Recommend, Administer or Refer. Interim Outcomes Report ACIP Recommendations for Adult Pneumococcal Immunization: Helping Pharmacists Assess, Recommend, Administer or Refer Grant ID: 29025501 Interim Outcomes Report https://www.powerpak.com/course/preamble/114079

More information

Medication Therapy Management: Improving Health and Saving Money

Medication Therapy Management: Improving Health and Saving Money Medication Therapy Management: Improving Health and Saving Money Ed Staffa, RPh Vice President, Pharmacy Mirixa Corporation estaffa@mirixa.com July 23, 2008 MTM At A Glance The U.S. health care system

More information

Texas Vendor Drug Program Specialty Drug List Process. February 2019

Texas Vendor Drug Program Specialty Drug List Process. February 2019 Texas Vendor Drug Program Specialty Drug List Process February 2019 Table of Contents Table of Contents...1 1 About the Specialty Drug List...2 1.1 Information for Pharmacies... 2 1.2 Information for Managed

More information

PrEP Implementation in San Francisco. Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health

PrEP Implementation in San Francisco. Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health PrEP Implementation in San Francisco Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health Why are new prevention strategies needed? New infections

More information

Oral Chemotherapy Panel

Oral Chemotherapy Panel Panel Disclosures Dr. Chen & Dr. Hudson-DiSalle no relevant financial relationships exist with commercial interests Oral Chemotherapy Panel Dr. Mancini - Speaker s Bureau for Millennium Pharmaceuticals

More information

Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital

Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital Reducing COPD Exacerbation Readmissions in a Community-Based Teaching Hospital Dawn Waddell, PharmD, BCPS Clinical Pharmacy Manager Lisa Kingdon, PharmD, BCPS Clinical Pharmacy Specialist Dawn Waddell

More information

An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder

An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder CONTENTS I. Need for an Alternative Payment Model for Opioid Use Disorder and Addiction... 2 A. Improving Services

More information

Commercial Health Insurance Claims Data. for Studying HIV/AIDS Care. Senior Scientist, Innovus Epidemiology. David D.

Commercial Health Insurance Claims Data. for Studying HIV/AIDS Care. Senior Scientist, Innovus Epidemiology. David D. Commercial Health Insurance Claims Data for Studying HIV/AIDS Care David D. Dore, PharmD, PhD Senior Scientist, Innovus Epidemiology Adjunct Assistant Professor, Alpert Medical School, Brown University

More information

The New Role of Cancer Patient Engagement in Value Based Models

The New Role of Cancer Patient Engagement in Value Based Models Mini Summit XIX: Case Studies in Specialty Medical Homes: How to Design APMs to Support Patients with Serious Health Conditions that Cannot be Managed by a PCP Ray Page, DO PhD The New Role of Cancer Patient

More information

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA 50315 (515) 725-1287 Fax 1-866-626-0216 Bruce Alexander, R.Ph., Pharm.D., BCPP Larry Ambroson, R.Ph. Casey Clor, M.D.

More information

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S.

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S. Speaker Brian K. Solow, MD, FAAFP Optum Life Sciences Irvine, CA, USA PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S. Brian K. Solow, MD, FAAFP Chief Medical Officer, Optum Life Sciences

More information

Leverage Healthcare Technology Applications to Improve Primary Nonadherence.

Leverage Healthcare Technology Applications to Improve Primary Nonadherence. Leverage Healthcare Technology Applications to Improve Primary Nonadherence. Page 2 Medication adherence starts with assessing a patient s opportunity for having positive outcomes on a specific therapy.

More information

Myriad Genetics Corporate Presentation 06/13/2018

Myriad Genetics Corporate Presentation 06/13/2018 Myriad Genetics Corporate Presentation 06/13/2018 Copyright 2016 2018 Myriad Genetics, Inc., all rights reserved. www.myriad.com. 1 Forward Looking Statements Some of the information presented here today

More information

Clinical Policy: Valganciclovir (Valcyte) Reference Number: CP.CPA.116 Effective Date: Last Review Date: Line of Business: Commercial

Clinical Policy: Valganciclovir (Valcyte) Reference Number: CP.CPA.116 Effective Date: Last Review Date: Line of Business: Commercial Clinical Policy: (Valcyte) Reference Number: CP.CPA.116 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important

More information

Primary Care Pharmacist Integration and Reimbursement Models

Primary Care Pharmacist Integration and Reimbursement Models Primary Care Pharmacist Integration and Reimbursement Models May 20, 2015 MODERATOR: Marie Smith, PharmD Palmer Professor and Assistant Dean, Practice and Public Policy Partnerships, UConn School of Pharmacy

More information

Strengthening our global leadership in treatment of addiction. Morgan Stanley Global Healthcare Conference September 13 th and 14 th 2018

Strengthening our global leadership in treatment of addiction. Morgan Stanley Global Healthcare Conference September 13 th and 14 th 2018 Strengthening our global leadership in treatment of addiction Morgan Stanley Global Healthcare Conference September 13 th and 14 th 2018 Forward Looking Statements This presentation contains certain statements

More information

Brantley M. Underwood Pharm.D., MBA PGY1 Community Pharmacy Resident Southwestern Oklahoma State University/Walgreen Co

Brantley M. Underwood Pharm.D., MBA PGY1 Community Pharmacy Resident Southwestern Oklahoma State University/Walgreen Co Brantley M. Underwood Pharm.D., MBA PGY1 Community Pharmacy Resident Southwestern Oklahoma State University/Walgreen Co Describe the benefits of using a mobile application as a medication reminder tool

More information

New patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit:

New patients approved for the Novo Nordisk PAP may only be eligible for insulin vials. For a full list of available products, please visit: The Novo Nordisk Diabetes Patient Assistance Program (PAP) provides medication to qualifying applicants at no charge. If the applicant qualifies under the Novo Nordisk Diabetes PAP guidelines, a 120-day

More information

Self-Insurance 2016 Q2 Update. Presented by Marcy Syman, Human Resources Director

Self-Insurance 2016 Q2 Update. Presented by Marcy Syman, Human Resources Director Self-Insurance 2016 Q2 Update Presented by Marcy Syman, Human Resources Director Management Committee 9-12-2016 Dollars in Millions Self-Insured Plan Costs Q2 2016 (Claims, admin fees and stop loss premium)

More information

Does Variation in the Physical Characteristics of Generic Drugs Affect Patients Experiences?

Does Variation in the Physical Characteristics of Generic Drugs Affect Patients Experiences? Does Variation in the Physical Characteristics of Generic Drugs Affect Patients Experiences? Results from a National Survey of Pharmacists and Patients Ameet Sarpatwari, J.D., Ph.D. Instructor in Medicine,

More information

Global Rheumatoid Arthritis Market: Trends and Opportunities ( )

Global Rheumatoid Arthritis Market: Trends and Opportunities ( ) Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018) Global Rheumatoid Arthritis Market Report Scope of the report The report titled Global Rheumatoid Arthritis Market: Trends and Opportunities

More information

Ensure access to and compliance with treatment for low-income uninsured Virginia residents living with HIV/AIDS

Ensure access to and compliance with treatment for low-income uninsured Virginia residents living with HIV/AIDS Public Health/ CHSB Lilibeth Grandas x1211 Sharron Martin x1239 Program Purpose Program Information Ensure access to and compliance with treatment for low-income uninsured Virginia residents living with

More information

What CEOs Don t Know about Health System Pharmacy

What CEOs Don t Know about Health System Pharmacy Pharmacy Executive Forum What CEOs Don t Know about Health System Pharmacy research technology consulting 2 Today s Presenters Rob Lazerow Managing Director The Advisory Board Company lazerowr@advisory.com

More information

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:

CARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription

More information

Practice Advisory on Drug Coverage Parity across Medical and Pharmacy Benefits

Practice Advisory on Drug Coverage Parity across Medical and Pharmacy Benefits Practice Advisory on Drug Coverage Parity across Medical and Pharmacy Benefits Introduction Oncology medications have historically been administered intravenously in a physician s office, infusion center

More information

Topic: Sovaldi, sofosbuvir Date of Origin: March 14, Committee Approval Date: August 15, 2014 Next Review Date: March 2015

Topic: Sovaldi, sofosbuvir Date of Origin: March 14, Committee Approval Date: August 15, 2014 Next Review Date: March 2015 Medication Policy Manual Policy No: dru332 Topic: Sovaldi, sofosbuvir Date of Origin: March 14, 2014 Committee Approval Date: August 15, 2014 Next Review Date: March 2015 Effective Date: October 1, 2014

More information

Addressing Gaps in MS Care. November 6, :00 AM - Noon

Addressing Gaps in MS Care. November 6, :00 AM - Noon Addressing Gaps in MS Care November 6, 2015 11:00 AM - Noon Learning Objectives Understand and confidently communicate the barriers to MS care caused by the shortage of healthcare providers with MS experience,

More information

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center

Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center at the Maritime Institute Pharmacy-Driven Inpatient

More information

340B Savings Equals Improved Patient Care

340B Savings Equals Improved Patient Care 10 th Annual 340B Coalition Winter Conference 340B Savings Equals Improved Patient Care Carol Millage, PharmD Pharmacy Director County of Santa Barbara Public Health February 7, 2014 Statement of Conflicts

More information

Team-Based Decision Support in Diabetes Outcomes and Costs

Team-Based Decision Support in Diabetes Outcomes and Costs Team-Based Decision Support in Diabetes Outcomes and Costs Session 89, 8:30 a.m. February 13, 2019 Gary Ozanich, Ph.D. - College of Informatics, Northern Kentucky University 1 Conflict of Interest Gary

More information

PREVENTATIVE COMMUNITY PHARMACY DIABETES MANAGEMENT PROGRAMS BROOKE HUDSPETH, PHARMD, CDE, MLDE KROGER DIABETES CARE

PREVENTATIVE COMMUNITY PHARMACY DIABETES MANAGEMENT PROGRAMS BROOKE HUDSPETH, PHARMD, CDE, MLDE KROGER DIABETES CARE PREVENTATIVE COMMUNITY PHARMACY DIABETES MANAGEMENT PROGRAMS BROOKE HUDSPETH, PHARMD, CDE, MLDE KROGER DIABETES CARE DISCLOSURE STATEMENT Brooke Hudspeth is employed by The Kroger Co. No other conflicts

More information

The Sustainability of Irish Pharmaceutical Expenditure. Valerie Walshe Ph.D. Economist

The Sustainability of Irish Pharmaceutical Expenditure. Valerie Walshe Ph.D. Economist The Sustainability of Irish Pharmaceutical Expenditure Valerie Walshe Ph.D. Economist valerie.walshe@hse.ie February 2015 Content Overview of Irish Health Services Community Drug Prescribing Trends Driving

More information

Letter to the AMGA Board of Directors... 1 Introduction... 3

Letter to the AMGA Board of Directors... 1 Introduction... 3 Table of Contents Letter to the AMGA Board of Directors... 1 Introduction... 3 Section I: Executive Summary Survey at a Glance... 6 Participant Profile... 10 Survey Methodology... 19 How to Use This Report...

More information

April 2o14. The 2013 Drug Trend Report Highlights

April 2o14. The 2013 Drug Trend Report Highlights April 2o14 The 2013 Drug Trend Report Highlights Express Scripts Reports Lowest Specialty Drug Trend Since 2007 In 2013, spending on prescription drugs increased 5.4% after several years of slower-paced

More information

Zoster Tdap. Marianne Langlois. Tetanus Diptheria (Td) Hepatitis A Hepatitis A & B combo

Zoster Tdap. Marianne Langlois. Tetanus Diptheria (Td) Hepatitis A Hepatitis A & B combo Marianne Langlois Zoster Tdap Tetanus Diptheria (Td) Hepatitis A Hepatitis A & B combo 2017 National Adult and Influenza Immunization Summit 5/9/2017 1 HFHS CEO Nancy Schlichting met with Merck Vaccine

More information

2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan

2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan 2016 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan Plan Details, Programs, and Policies Table of Contents Click on the links below to be taken to that

More information

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Finance Committee. Hearing on:

Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Finance Committee. Hearing on: Statement Of The National Association of Chain Drug Stores For U.S. Senate Finance Committee Hearing on: 10:30 a.m. 215 Dirksen Senate Office Building National Association of Chain Drug Stores (NACDS)

More information

How health plans can improve cancer care: from utilization management to delivery reform

How health plans can improve cancer care: from utilization management to delivery reform Quality health plans & benefits Healthier living Financial well being Intelligent solutions How health plans can improve cancer care: from utilization management to delivery reform Michael Kolodziej, M.D.,

More information

Navigating Immuno-Oncology Coverage & Reimbursement Issues

Navigating Immuno-Oncology Coverage & Reimbursement Issues Navigating Immuno-Oncology Coverage & Reimbursement Issues Niesha Griffith, RPh, MS, FASHP Administrator of Oncology Pharmacy and Infusion Services at the Arthur G. James Cancer Hospital and Richard J.

More information